PRESS RELEASE published on 09/23/2026 at 07:30, 1 month 4 days ago Inside Information / News release on accounts, results Sensorion reports 2026 half-year results, provides corporate update, and announces availability of the half-year report. Progress on gene therapy programs showcased Financial Highlights Gene Therapy Clinical Trial Sensorion 2026 Results
BRIEF published on 09/18/2026 at 07:35, 1 month 9 days ago Sensorion unveils details of the SENS-601 Program Day Gene Therapy Hearing Loss SENS-601 Sensory HearConnex
BRIEF published on 09/18/2026 at 07:35, 1 month 9 days ago Sensorion dévoile les détails du SENS-601 Program Day Thérapie Génique Sensorion Perte Auditive SENS-601 HearConnex
PRESS RELEASE published on 09/18/2026 at 07:30, 1 month 9 days ago Inside Information / Other news releases Sensorion announces connection details for its SENS-601 Program Day on September 22, 2026, featuring Prof. Christine Petit and Dr. Sharon Cushing. Details available on the Company's website Gene Therapy Sensorion SENS-601 Program Day Connection Details
PRESS RELEASE published on 09/18/2026 at 07:30, 1 month 9 days ago Informations privilégiées / Autres communiqués Sensorion annonce les modalités de connexion pour son SENS-601 Program Day du 22 septembre 2026, détaillant les conférenciers et l'accès à l'événement en ligne Thérapie Génique Sensorion Perte Auditive Connexion SENS-601 Program Day
BRIEF published on 09/16/2026 at 07:35, 1 month 11 days ago Sensorion envisage une introduction en bourse aux États-Unis Biotechnologie SEC Introduction En Bourse Sensorion Thérapies Auditives
BRIEF published on 09/16/2026 at 07:35, 1 month 11 days ago Sensorion is considering an initial public offering in the United States Biotechnology Initial Public Offering DRY Sensory Auditory Therapies
BRIEF published on 09/16/2026 at 07:35, 1 month 11 days ago Sensorion soumet un projet d'offre publique initiale Biotechnologie Introduction En Bourse Dépôt Auprès De La SEC Audiologie Sensorion
BRIEF published on 09/16/2026 at 07:35, 1 month 11 days ago Sensorion Submits Initial Public Offering Draft Biotechnology IPO SEC Filing Audiology Sensorion
PRESS RELEASE published on 09/16/2026 at 07:30, 1 month 11 days ago Inside Information / Other news releases Sensorion announces submission of draft registration statement to SEC for potential U.S. IPO. Company focuses on novel therapies for hearing loss disorders SEC Sensorion Hearing Loss Therapies Draft Registration Statement U.S. IPO
Published on 10/27/2026 at 15:00, 2 hours 28 minutes ago PPX Intercepts High-Grade Gold, Silver, and Copper at Callanquitas, with 13.28 g/t Au, 5,204 g/t Ag and 5.4% Cu Over 1.0 m; and Completes the First Drill Hole at Portachuelos
Published on 10/27/2026 at 14:55, 2 hours 33 minutes ago Sun Valley Minerals Commences Trading on the TSX Venture Exchange; Launches Maiden Drill Program at Tarumán Main
Published on 10/27/2026 at 14:15, 3 hours 13 minutes ago As Ebola Spreads to Multiple Countries, the Importance of NV-387 Oral Gummies Treatment Cannot be Understated - Phase II Clinical Trial Advancing Towards the Second Part, Says NanoViricides
Published on 10/27/2026 at 13:45, 3 hours 43 minutes ago Sekur Private Data Receives US$3.4 Million Per Year Quotation Request from African Government for 1,000 Command Bundle Licenses, 200 SekurOne Accounts and 200 Sekur Tactical Mobile Routers
Published on 10/27/2026 at 13:31, 3 hours 57 minutes ago First Breach Completes First Test Flight of Long Range Strike Drone
Published on 10/27/2026 at 17:15, 13 minutes ago EQS-Adhoc: KAP AG ADJUSTS GUIDANCE FOR THE 2026 FINANCIAL YEAR
Published on 10/27/2026 at 15:49, 1 hour 39 minutes ago EQS-Adhoc: aconnic AG prolongs existing debt financing facility of EUR 23 million
Published on 10/27/2026 at 15:20, 2 hours 8 minutes ago VeriPark achieves the 2026-2027 Microsoft AI Business Solutions Inner Circle award
Published on 10/27/2026 at 15:05, 2 hours 23 minutes ago Ciklum and NiCE Partner to Bring Agentic AI to Enterprise Customer Experiences
Published on 10/27/2026 at 15:00, 2 hours 28 minutes ago BIO-Europe 2026 to Convene Global Biopharma Leaders in Cologne as Dealmaking Confidence Grows
Published on 10/26/2026 at 18:11, 23 hours 17 minutes ago Declaration of transactions on own shares from October 19, 2026 to October 25, 2026
Published on 10/26/2026 at 18:11, 23 hours 17 minutes ago Déclaration des transactions sur actions propres réalisées du 19/10/2026 au 25/10/2026
Published on 10/26/2026 at 17:45, 23 hours 43 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 10/26/2026 at 17:45, 23 hours 43 minutes ago Infotel : Déclaration des transactions sur actions propres réalisées du 19 au 23 octobre 2026 dans le cadre du programme de rachat d’actions.
